Jan 11, 2015

Tech giants quietly investing in Synthetic Biology

Posted by in category: biotech/medical



So if I asked what you think will fuel the growth of today’s technology giants in the next 15 years, what would your answer be? You might say familiar or trendy terms, such as user growth or the Internet of Things. Or perhaps that the companies with the most innovative products and services will reign king in tomorrow’s tech markets. And while those are likely partially correct answers, there’s a tremendous amount of growth to be had from a rather unlikely source.

It might be difficult to believe that companies that have traditionally relied on silicon chips, mobile apps, and lines of software code could profit from something as seemingly disconnected as making biological engineering as predictable as traditional engineering fields, but a closer look into research and development spending hints that it may not be that far-fetched after all. Why are Autodesk (NASDAQ: ADSK) , Intel (NASDAQ: INTC) , and Microsoft (NASDAQ: MSFT) quietly investing in synthetic biology, and what could it mean for investors?

Read more


Comments — comments are now closed.

  1. Luis says:

    Are we talking about RoboCop and Universal Soldier likes or prostetics? Personally, memory enhancments and faster inputs/outputs for humans would perk my interest.

    Hi. I’m your Doctor. You have a healthy girl. Now you have a decision to make. What communications implant shall we install on her today?

  2. Elias says:

    There are more potential in nature to solve many of the big challenges. For example, materials and energy from biological resources are economically and environmentally more viable in the future. Outside of the benefits of design and understand the genetics circuits and proteins interaction that could be developed with new “devices” and “parts” from synbio (in Health for example).